Skip to content

Understanding Which Drug Is Indicated for Urinary Retention

3 min read

According to Yale Medicine, one or more medications, including alpha-blockers and 5-alpha reductase inhibitors, may be prescribed to ease symptoms of urinary retention. But the critical step is determining which drug is indicated for urinary retention, as the best choice depends heavily on the underlying cause, whether it's related to an enlarged prostate, nerve issues, or other factors.

Quick Summary

Treatment for urinary retention is not one-size-fits-all, requiring a specific medication based on the cause. Common options include alpha-blockers for benign prostatic hyperplasia (BPH), 5-alpha reductase inhibitors for prostate size reduction, and cholinergic agonists for certain nerve-related issues. Some drugs can also cause retention.

Key Points

  • Alpha-blockers for BPH: Alpha-blockers like tamsulosin are typically the first choice for relieving urinary retention caused by an enlarged prostate by relaxing muscles in the area.

  • 5-ARIs for long-term BPH: 5-alpha reductase inhibitors like finasteride are used for long-term management in men with large prostates by slowly shrinking the gland over several months.

  • Bethanechol for non-obstructive retention: For retention caused by nerve or muscle dysfunction, the cholinergic agonist bethanechol helps by stimulating bladder contraction.

  • Medications can cause retention: Many drugs, including decongestants, antidepressants, and opioids, can cause or worsen urinary retention by interfering with bladder function.

  • Combination therapy offers benefits: Combining an alpha-blocker and a 5-ARI can be more effective for men with moderate-to-severe BPH, offering both quick relief and long-term prostate shrinkage.

  • Female retention treatments vary: While tamsulosin is used off-label for some female retention issues, treatments for women depend on the underlying cause, which may be different from BPH.

In This Article

What is Urinary Retention?

Urinary retention is the inability to completely empty the bladder. It can be acute, a painful emergency where urination is impossible, or chronic, involving persistently incomplete emptying. While acute cases often require immediate catheterization, long-term treatment frequently involves medication tailored to the underlying cause.

Medications for Benign Prostatic Hyperplasia (BPH)-Related Retention

Benign prostatic hyperplasia (BPH), an enlarged prostate, is a frequent cause of urinary retention, particularly in older men. Medications for BPH aim to relieve obstruction caused by the enlarged gland.

Alpha-blockers

Alpha-blockers are a common initial treatment for BPH-related retention. They work by relaxing smooth muscles in the prostate and bladder neck, improving urine flow.

  • Examples: Tamsulosin (Flomax), Alfuzosin (Uroxatral), Doxazosin (Cardura), and Terazosin.
  • Action: Symptom relief can occur within days to weeks.
  • Side Effects: Potential side effects include dizziness and ejaculatory problems.

5-Alpha Reductase Inhibitors (5-ARIs)

For men with significantly enlarged prostates, 5-ARIs are used to shrink the prostate over time.

  • Examples: Finasteride (Proscar) and Dutasteride (Avodart).
  • Action: These drugs reduce prostate size by blocking a hormone that promotes growth. Their effect is gradual, taking several months.
  • Side Effects: Side effects can include reduced libido and erectile dysfunction.

Medications for Non-Obstructive Retention

Urinary retention can also result from problems with bladder muscle or nerve function rather than a blockage, as seen in neurogenic bladder or post-operative retention.

Cholinergic Agonists

Bethanechol (Urecholine) is a primary medication for non-obstructive urinary retention.

  • Mechanism: It stimulates bladder muscle contraction, aiding emptying.
  • Usage: Typically used for acute non-obstructive retention after surgery or delivery, or for certain neurogenic bladder conditions.
  • Side Effects: Possible side effects include gastrointestinal issues and flushing.

Combination Therapy and Other Options

Combining an alpha-blocker and a 5-ARI can be more effective for men with moderate-to-severe BPH, offering both quick symptom relief and long-term prostate shrinkage. Tadalafil (Cialis) may also be used for BPH/LUTS.

For women, treatment is guided by the specific cause. Low-dose alpha-blockers like tamsulosin have been used off-label for issues like a non-relaxing urethra.

Medications That Can Cause Urinary Retention

Certain medications can cause or worsen urinary retention due to anticholinergic or sympathomimetic effects. These include:

  • Anticholinergics
  • Sympathomimetics (decongestants)
  • Some antidepressants
  • Opioids
  • NSAIDs

Stopping or changing these medications may resolve the retention. For opioid-induced retention, switching pain medication or using specific antagonists might help.

Comparison of Common Urinary Retention Medications

Drug Class Examples Mechanism of Action Indication Time to Effect Primary Side Effects
Alpha-Blockers Tamsulosin, Alfuzosin Relaxes prostate and bladder neck muscles BPH Days to weeks Dizziness, headache, retrograde ejaculation
5-ARIs Finasteride, Dutasteride Inhibits conversion of testosterone to DHT, shrinking prostate BPH with enlarged prostate Several months Sexual dysfunction (ED, decreased libido), gynecomastia
Cholinergic Agonists Bethanechol Stimulates bladder (detrusor) muscle contraction Non-obstructive retention (neurogenic, post-op) 30-90 minutes (oral) GI distress, flushing, sweating, low blood pressure

Conclusion

The appropriate drug for urinary retention depends entirely on its underlying cause. Alpha-blockers and 5-ARIs are common for BPH, while bethanechol is used for non-obstructive issues. Some medications can also cause retention. A proper diagnosis from a healthcare provider is essential to determine the most suitable and safest treatment. For more information on BPH management, refer to the Urology Care Foundation.

Frequently Asked Questions

No, you should not self-treat urinary retention with over-the-counter (OTC) medications. In fact, many common OTC products, such as decongestants and antihistamines, can worsen urinary retention. Always consult a healthcare professional for diagnosis and treatment.

Alpha-blockers provide relatively fast relief compared to 5-ARIs. Most people experience an improvement in urine flow and symptoms within days to a few weeks of starting treatment.

Bethanechol is not effective for all types of urinary retention. It is specifically used for non-obstructive retention, such as that caused by a weak bladder muscle after surgery, delivery, or in some cases of neurogenic bladder. It is contraindicated in cases where there is a physical blockage.

No. While finasteride and dutasteride help prevent urinary retention in the long term by shrinking the prostate, they are not effective for treating acute urinary retention. They take several months to have their full effect.

The initial, and often immediate, treatment for acute urinary retention is catheterization to drain the bladder and relieve the pain and pressure. After the bladder is drained, a healthcare provider will determine the underlying cause and prescribe a long-term treatment plan, which may include medication.

Yes. Medications used to treat an overactive bladder, such as anticholinergics (e.g., oxybutynin), work by relaxing the bladder muscle, and can, in some cases, cause or worsen urinary retention. For this reason, a doctor must carefully evaluate a patient's symptoms before prescribing these drugs.

Yes, but the options differ from those for BPH in men. For non-obstructive retention, bethanechol may be used. For functional obstruction, such as a non-relaxing urethra, alpha-blockers like tamsulosin have been used off-label. Treatment depends on the specific cause, and a specialist should be consulted.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.